| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to a human papillomavirus-associated cancer strategic |
|
|
plan developed by the Department of State Health Services. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. (a) The Department of State Health Services |
|
|
shall develop a strategic plan to significantly reduce morbidity |
|
|
and mortality from human papillomavirus-associated cancer. |
|
|
(b) In developing the strategic plan, the Department of |
|
|
State Health Services shall collaborate with the Cancer Prevention |
|
|
and Research Institute of Texas and may convene any necessary |
|
|
workgroups. The members of a workgroup may include: |
|
|
(1) health care providers specializing in human |
|
|
papillomavirus-associated cancer prevention, screening, |
|
|
treatment, or research; |
|
|
(2) physicians specializing in primary care, |
|
|
pediatrics, or obstetrics and gynecology; |
|
|
(3) mid-level health care practitioners; |
|
|
(4) cancer epidemiologists; |
|
|
(5) representatives of general academic teaching |
|
|
institutions as defined by Section 61.003, Education Code, and |
|
|
medical and dental units as defined by Section 61.003, Education |
|
|
Code; |
|
|
(6) middle school, high school, or college health |
|
|
educators; |
|
|
(7) human papillomavirus-associated cancer survivors; |
|
|
(8) representatives from geographic areas or other |
|
|
population groups at higher risk of human |
|
|
papillomavirus-associated cancer; |
|
|
(9) representatives of community-based and |
|
|
faith-based organizations involved in providing education, |
|
|
awareness, or support relating to human papillomavirus-associated |
|
|
cancer; or |
|
|
(10) other people the department determines are |
|
|
necessary. |
|
|
(c) In developing the strategic plan, the Department of |
|
|
State Health Services shall: |
|
|
(1) identify barriers to effective prevention, |
|
|
screening, and treatment for human papillomavirus-associated |
|
|
cancer, including specific barriers affecting providers and |
|
|
patients; |
|
|
(2) identify methods to increase the number of people |
|
|
vaccinated against human papillomavirus; |
|
|
(3) identify methods to increase use of evidence-based |
|
|
screening to enhance the number of people screened regularly for |
|
|
human papillomavirus-associated cancer; |
|
|
(4) review current technologies and best practices for |
|
|
human papillomavirus-associated cancer screening; |
|
|
(5) review technology available to diagnose and |
|
|
prevent infection by human papillomavirus; |
|
|
(6) develop methods for creating partnerships with |
|
|
public and private entities to increase awareness of human |
|
|
papillomavirus-associated cancer and of the importance of |
|
|
vaccination education and regular screening; |
|
|
(7) review current prevention, screening, treatment, |
|
|
and related activities in this state and identify areas in which the |
|
|
services for those activities are lacking; |
|
|
(8) estimate the annual direct and indirect state |
|
|
health care costs attributable to human papillomavirus-associated |
|
|
cancers; |
|
|
(9) identify actions necessary to increase |
|
|
vaccination and screening rates and reduce the morbidity and |
|
|
mortality from human papillomavirus-associated cancer and |
|
|
establish a schedule for implementing those actions; and |
|
|
(10) make recommendations to the legislature on policy |
|
|
changes and funding needed to implement the strategic plan. |
|
|
(d) Not later than December 31, 2016, the Department of |
|
|
State Health Services shall deliver to the governor and members of |
|
|
the legislature the strategic plan and recommendations on goal |
|
|
implementation and schedule compliance related to the strategic |
|
|
plan. |
|
|
(e) This section expires January 1, 2017. |
|
|
SECTION 2. This Act takes effect September 1, 2015. |